v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05498493 |
|
Full text link
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : March 14, 2023, midnight Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : March 14, 2023, midnight Source : ClinicalTrials.gov |
nadia.zubair@mountsinai.org |
|
Registration date
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
2022-08-12 |
|
Recruitment status
Last imported at : Aug. 23, 2022, 8:30 p.m. Source : ClinicalTrials.gov |
Recruiting |
|
Study design
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Long covid |
|
Inclusion criteria
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: adults ≥18 years of age have a confirmed sars-cov-2 infection (positive pcr or are serum antibody positive [against spike protein if unvaccinated or n-capsid peptide if vaccinated]) speak english have objective mild to moderate cognitive impairment, which will be defined as impairment in executive function (a z-score >1.5 standard deviations below the normative mean) and in at least one other cognitive domain endorse comfort and familiarity with technology. |
|
Exclusion criteria
Last imported at : March 14, 2023, midnight Source : ClinicalTrials.gov |
no method of contact major neurocognitive disorder, as defined by a score <17 on the montreal cognitive assessment (moca) history of pre-covid-19 neurologic disease (e.g., stroke) history of severe head injury (as defined by loss of consciousness >30 minutes) ongoing substance use disorder (mini international neuropsychiatric interview version 7.0.2 [mini] or alcohol use disorders test-consumption [audit-c] >8) unstable medical, neurologic, or psychiatric conditions precluding participation in research activities, and contraindication for mri (e.g., metallic/electronic implants). not involved in cognitive rehabiliation/training or daily meditative practices during study enrollment |
|
Number of arms
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Icahn School of Medicine at Mount Sinai |
|
Inclusion age min
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
100 |
|
Countries
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
United States |
|
Type of patients
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
|
Severity scale
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
60 |
|
primary outcome
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Acceptability Scale;Dropout number;Enrollment yield;Resting state functional connectivity (rsFC);Staff Practicality;Trail Making Test - Part B;Treatment Credibility and Expectancy Questionnaire.;Wisconsin Card Sorting Task (WCST)-64 |
|
Notes
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : Aug. 13, 2022, 5:30 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2109, "treatment_name": "Cognitive rehabilitation exercises", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "Control", "treatment_id": 961, "treatment_name": "Patient education", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |